April 2012

30 April 2012 Appendix 4C - Quarterly Cashflow report

16 April 2012 Shareholder Update: April 2012

March 2012

26 March 2012 Starpharma commences phase 3 trial of VivaGel

22 March 2012 Starpharma commences pivotal phase 3 VivaGel trials for bacterial vaginosis treatment

9 March 2012 International licensing expert Peter Turvey joins Starpharma Board

6 March 2012 Starpharma presenting at Citi investment conference in London

February 2012

1 February 2012 Starpharma’s dendrimers improve efficacy of docetaxel in animals

December 2011

19 December 2011 Starpharma's drug delivery program with Lilly advances

8 December 2011 Starpharma SPP closes heavily oversubscribed; completing $35m financing

November 2011

24 November 2011 M&G Substantial Shareholder Notice

16 November 2011 Starpharma completes A$32 million placement; SPP to follow

September 2011

6 September 2011 Starpharma elevated to S&P/ASX300 index